Public Market Listing
Live quotes, historical charts, and market capitalization for Nippon Kayaku are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(2 total)
| Target & Modality | |||
|---|---|---|---|
| Approved | ROS1Small molecule | Non-Small Cell Lung Cancer ROS1-Positive Non-Small Cell Lung Cancer | |
| Phase 2 | apoptosis via reactive oxygen species (ROS) generation and mitochondrial disruptionSmall molecule | Non-Hodgkin Lymphoma Peripheral T-Cell Lymphoma |
Upcoming events
(2 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
Regulatory and conference events
(6)
Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.
Coming up
Recent
Financial reports
No financial reports recorded.